title: First hematopoietic cell transplantation in Uzbekistan: Progress through education and cooperation.
abstract: HCT rates are one of the important parameters defining developmental stage of a given country. There is a steady increase in HCT activity on both sides of Atlantic. But in certain parts of the world, HCT activities have yet to begin. Here we report the history of the establishment of the first HCT center and its preliminary activity in Tashkent-Uzbekistan through close cooperation between Turkish Cooperation and Coordination Agency (TIKA) and Uzbekistan Ministry of Health. As of 2014, a total of 10 multiple myeloma patients successfully underwent autologous HCT in Uzbekistan. This encouraging project may be seen as a good example for other developing countries.
authors.affiliation: Scientific Research Institute of Hematology and Blood Transfusion, Tashkent, Uzbekistan.
authors.forename: Khamid
authors.initials: K
authors.lastname: Karimov
authors.affiliation: Hematology and HCT Clinic, Ankara Oncology Education and Research Hospital, Ankara, Turkey. Electronic address: emretekgunduz@yahoo.com.
authors.forename: Emre
authors.initials: E
authors.lastname: Tekgündüz
authors.affiliation: Scientific Research Institute of Hematology and Blood Transfusion, Tashkent, Uzbekistan.
authors.forename: Alonur
authors.initials: A
authors.lastname: Saidov
authors.affiliation: Hematology and HCT Clinic, Ankara Oncology Education and Research Hospital, Ankara, Turkey.
authors.forename: Ömür
authors.initials: Ö
authors.lastname: Kayıkçı
authors.affiliation: Scientific Research Institute of Hematology and Blood Transfusion, Tashkent, Uzbekistan.
authors.forename: Kodirzhon
authors.initials: K
authors.lastname: Boboev
authors.affiliation: Hematology and HCT Clinic, Ankara Oncology Education and Research Hospital, Ankara, Turkey.
authors.forename: Şerife
authors.initials: Ş
authors.lastname: Koçubaba
authors.affiliation: Scientific Research Institute of Hematology and Blood Transfusion, Tashkent, Uzbekistan.
authors.forename: Abdurakhmon
authors.initials: A
authors.lastname: Kayumov
authors.affiliation: Therapeutic Apheresis Center, Ankara Oncology Education and Research Hospital, Ankara, Turkey.
authors.forename: Ali
authors.initials: A
authors.lastname: Kılınç
authors.affiliation: Therapeutic Apheresis Center, Ankara Oncology Education and Research Hospital, Ankara, Turkey.
authors.forename: Gülşen
authors.initials: G
authors.lastname: Adıbelli
authors.affiliation: Scientific Research Institute of Hematology and Blood Transfusion, Tashkent, Uzbekistan.
authors.forename: Abdumannon
authors.initials: A
authors.lastname: Isroilov
authors.affiliation: Hematology and HCT Clinic, Ankara Oncology Education and Research Hospital, Ankara, Turkey.
authors.forename: Tuğçe Nur
authors.initials: TN
authors.lastname: Türközü
authors.affiliation: Ankara Oncology Education and Research Hospital, Ankara, Turkey.
authors.forename: Halil Yılmaz
authors.initials: HY
authors.lastname: Sur
authors.affiliation: Yıldırım Beyazıt University Medical Faculty, Department of Internal Medicine, Division of Oncology, Ankara, Turkey.
authors.forename: Nurullah
authors.initials: N
authors.lastname: Zengin
authors.affiliation: Yıldırım Beyazıt University Medical Faculty, Department of Internal Medicine, Division of Hematology, Ankara, Turkey.
authors.forename: Fevzi
authors.initials: F
authors.lastname: Altuntaş
mesh_terms: D003299:Cooperative Behavior; D004493:Education; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000473:pathology; D014610:Uzbekistan
keywords: HCT; Hematopoietic cell transplantation; Uzbekistan